CHAD HANCOCK: Open Payments
NPI 1700405826 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 34 payments from 15 companies in 2025. Trend: 2023 $453 · 2024 $808 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $152 |
| Amgen Inc. | 4 | $94 |
| PFIZER INC. | 5 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Boston Scientific Corporation | 1 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Edwards Lifesciences Corporation | 1 | $35 |
| HEARTFLOW, INC. | 1 | $25 |
Products named: LEQVIO, REPATHA, ELIQUIS, Kerendia, WATCHMAN, JARDIANCE, FARXIGA, VYNDAQEL.
Industry payments across CO — which companies pay providers there.
